Outcrop Silver & Gold Corporation press release

Today's Research Reports on Resverlogix, IMV, BELLUS Health and Hamilton Thorne

2018-08-08

TSXV - TSX Venture Exchange · Silver · Gold · Copper · Canada

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.comand get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Resverlogix Corp. https://rdinvesting.com/news/?ticker=RVX.TO

IMV Inc. https://rdinvesting.com/news/?ticker=IMV.TO

BELLUS Health Inc. https://rdinvesting.com/news/?ticker=BLU.TO

Hamilton Thorne Ltd. https://rdinvesting.com/news/?ticker=HTL.V

Resverlogix's stock jumped 7.12% Tuesday, to close the day at $3.46. The stock recorded a trading volume of 494,235 shares, which was above its three months average volume of 169,841 shares. In the last year, Resverlogix's shares have traded in a range of 1.11 - 3.77. The share price has gained 211.71% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $2.47 is greater than its 200-day moving average of $1.83. Shares of Resverlogix have gained approximately 31.06 percentyear-to-date.

Access RDI's Resverlogix Corp. Research Report at: https://rdinvesting.com/news/?ticker=RVX.TO

On Tuesday, shares of IMVrecorded a trading volume of 19,705 shares, which was below the three months average volume of 49,898 shares. The stock ended the day 2.77% lower at 6.32. The share price has gained 89.79% from its 52 weeklow with a 52 weektrading range of 3.33 - 9.49. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $6.49 is below its 200-day moving average of $6.68. Shares of IMVhave fallen approximately 16.09 percentyear-to-date.

Access RDI's IMV Inc. Research Report at: https://rdinvesting.com/news/?ticker=IMV.TO

BELLUS Health's stock jumped 5.26% Tuesday, to close the day at $0.60. The stock recorded a trading volume of 46,956 shares, which was below its three months average volume of 249,241 shares. In the last year, BELLUS Health's shares have traded in a range of 0.28 - 0.55. The share price has gained 114.29% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.48 is greater than its 200-day moving average of $0.42. Shares of BELLUS Health have gained approximately 57.89 percentyear-to-date.

Access RDI's BELLUS Health Inc. Research Report at: https://rdinvesting.com/news/?ticker=BLU.TO

On Tuesday, shares of Hamilton Thorne recorded a trading volume of 413,500 shares, which was above the three months average volume of 125,961 shares. The stock ended the day 2.15% higher at 0.95. The share price has gained 41.79% from its 52 weeklow with a 52 weektrading range of 0.67 - 1.02. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.91 is greater than its 200-day moving average of $0.84. Shares of the company are trading at a Price to Earnings ratio of 19.39. Shares of Hamilton Thorne have gained approximately 25 percentyear-to-date.

Access RDI's Hamilton Thorne Ltd. Research Report at: https://rdinvesting.com/news/?ticker=HTL.V

Our Actionable Research on Resverlogix Corp. (TSX :RVX.TO) and IMV Inc. (TSX :IMV.TO) and BELLUS Health Inc. (TSX :BLU.TO) and Hamilton Thorne Ltd. (TSXV :HTL.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealernor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com